Head to Head Survey: Viant Technology (NASDAQ:DSP) and Tempus AI (NASDAQ:TEM)

Viant Technology (NASDAQ:DSP) and Tempus AI (NASDAQ:TEM) are both business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.

Institutional and Insider Ownership

11.4% of Viant Technology shares are owned by institutional investors. Comparatively, 24.2% of Tempus AI shares are owned by institutional investors. 28.8% of Viant Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Viant Technology and Tempus AI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Viant Technology	0.47%	-5.67%	-3.78%
Tempus AI	N/A	N/A	-111.38%

Earnings & Valuation

This table compares Viant Technology and Tempus AI”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viant Technology	$263.59 million	4.66	-$3.44 million	$0.06	325.50
Tempus AI	$640.44 million	8.74	-$289.81 million	N/A	N/A

Viant Technology has higher earnings, but lower revenue than Tempus AI.

Analyst Ratings

This is a summary of recent ratings for Viant Technology and Tempus AI, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viant Technology	0	0	8	0	3.00
Tempus AI	0	3	9	0	2.75

Viant Technology presently has a consensus price target of $17.75, suggesting a potential downside of 9.11%. Tempus AI has a consensus price target of $56.00, suggesting a potential upside of 57.57%. Given Tempus AI’s higher possible upside, analysts plainly believe Tempus AI is more favorable than Viant Technology.

Summary

Tempus AI beats Viant Technology on 6 of the 11 factors compared between the two stocks.

About Viant Technology

Viant Technology Inc. operates as an advertising technology company. It provides Household ID, a people-based innovation that combines digital and personal identifiers into a normalized household profile; AI Bid Optimizer, solution that uses AI to analyze historical bid opportunities to predict the lowest media cost for desired advertisement; and Viant Data Platform, which offers marketers control over their own data with actionable insights into their marketing initiatives within a single platform. The company also offers Holistic, an omnichannel DSP for marketers and their agencies to manage omnichannel campaigns and access metrics from each channel to inform decisions in other channels; Viant Identity Graph, which reduces or eliminates the need for cookies by enabling matching of people-based identifiers that anchor digital identifiers that allows marketers to reach targeted consumers in a privacy-conscious manner; and Direct Access, a path optimization program. In addition, it provides campaign analysis and data intelligence tool that empowers customers with differentiated insights, including conversion lift, multi-touch attribution, foot-traffic data reports, digital-out-of-home lift, sales reporting, and ROAS analytics; and self-service platform that provides customers with transparency and control over their advertising campaigns and underlying data infrastructure. The company sells its platform through a direct sales team focused on business development in various markets. It serves purchasers of programmatic advertising inventory; and large, independent, and mid-market advertising agencies, as well as marketers. The company was founded in 1999 and is headquartered in Irvine, California.

About Tempus AI

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.